CTRI/2020/09/027557尚未招募4 期
An Open Label, Prospective, Non-comparative, Multicentric, Single Arm, Active Post Marketing Surveillance Study to Evaluate the Safety, Tolerability and Efficacy of FDC of Epalrestat 150 mg + Pregabalin 150 mg Bilayered Sustained Release Tablets in Adult Patients for the treatment of pain due to Diabetic Peripheral Neuropathy
Aeon Formulations Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Adults male or female patients aged 18 to 65 years (both inclusive), diagnosed with pain due to diabetic peripheral neuropathy and who require treatment with FDC of Epalrestat 150 mg + Pregabalin 150 mg Tablets as part of their routine treatment regimen
排除标准
- •1.Patients with known hypersensitivity to Pregabalin / Epalrestat.
- •2.Females of childbearing age not using effective contraception/nursing & pregnant females.
- •3.Patients predisposed to Thrombocytopenia / liver dysfunction / renal impairment.
研究者
相似试验
尚未招募
4 期
A clinical study to evaluate the safety and efficacy of Tropicamide, Phenylephrine and Lidocaine injection in patients undergoing lens replacement surgery.CTRI/2024/01/062038Appasamy Ocular Devices (P) Ltd.
尚未招募
4 期
Post Marketing Surveillance Study to Evaluate the Safety, Tolerability and Efficacy of FDC of Pregabalin 75 mgand Nortriptyline 10 mg Tablets in Adult Patients for the treatment of Neuropathic PaiCTRI/2020/09/027603Aeon Formulations Pvt Ltd
已完成
4 期
A Prospective, Open-label, Non-comparative, Multi-centric Active PMS to evaluate efficacy and safety of STOMAFIT ORAL LIQUID containing Liquor Bismuth Ammonium Citrate 2.5ml, Belladonna Dry Extract 9mg, Thymol 0.15mg and Menthol 0.2 mg in Gastritis or Gastroesophageal Reflux Disease (GERD)CTRI/2020/03/023787SUNCARE FORMULATIONS PVT LTD200
尚未招募
3 期
Clinical Study on Kesh21 Hair Oil for Hair Growth PotentialCTRI/2023/07/054992OnTop Pharmaceuticals Pvt. Ltd.
已完成
Unknown
A study to determine safety and effectiveness of Budesonide-Formoterol given through the Ciphaler device in patients with Asthma.CTRI/2023/06/053727Cipla Ltd200